Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Noble Romans (NROM) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Noble Romans (NROM) over the last 15 years, with Q3 2025 value amounting to 19.77%.

  • Noble Romans' EBITDA Margin rose 90300.0% to 19.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.68%, marking a year-over-year increase of 4600.0%. This contributed to the annual value of 9.74% for FY2024, which is 141900.0% down from last year.
  • According to the latest figures from Q3 2025, Noble Romans' EBITDA Margin is 19.77%, which was up 90300.0% from 22.4% recorded in Q2 2025.
  • In the past 5 years, Noble Romans' EBITDA Margin ranged from a high of 35405.24% in Q1 2021 and a low of 11.86% during Q4 2022
  • Moreover, its 5-year median value for EBITDA Margin was 13.74% (2023), whereas its average is 2902.27%.
  • As far as peak fluctuations go, Noble Romans' EBITDA Margin surged by 353835800bps in 2021, and later tumbled by -354006500bps in 2022.
  • Over the past 5 years, Noble Romans' EBITDA Margin (Quarter) stood at 2.95% in 2021, then crashed by -302bps to 11.86% in 2022, then surged by 276bps to 20.87% in 2023, then plummeted by -91bps to 1.85% in 2024, then soared by 971bps to 19.77% in 2025.
  • Its EBITDA Margin was 19.77% in Q3 2025, compared to 22.4% in Q2 2025 and 13.34% in Q1 2025.